AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 3rd, 2022 • G Medical Innovations Holdings Ltd. • Surgical & medical instruments & apparatus
This Amended and Restated Registration Rights Agreement (this “Agreement”) is made and entered into as of February 1, 2022, between G Medical Innovations Holdings Ltd., a Cayman Islands exempted company (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement amends and restates that certain registration rights agreement dated as of January 30, 2022.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 3rd, 2022 • G Medical Innovations Holdings Ltd. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 1, 2022, between G Medical Innovations Holdings Ltd., a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature page hereto (including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
ORDINARY SHARE PURCHASE WARRANT G MEDICAL INNOVATIONS HOLDINGS LTD.Ordinary Share Purchase Warrant • February 3rd, 2022 • G Medical Innovations Holdings Ltd. • Surgical & medical instruments & apparatus
THIS ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Lind Global Fund II LP or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 2, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 2, 2027 (the “Termination Date”), but not thereafter, to subscribe for and purchase from G Medical Innovations Holdings Ltd., a Cayman Islands exempted company (the “Company”), up to 20,000 ordinary shares, par value $0.09 per share (the “Ordinary Shares”) (as subject to adjustment hereunder, the “Warrant Shares”). This Warrant was issued pursuant to Sections 2.1 and 2.2 of that certain Securities Purchase Agreement, dated as of January 31, 2022, by and between the Company, the Holder and other purchasers signatory thereto (as may be amended, amended and restated, supplemented or otherwise modified from t
